Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs

Summary

Nonsteroidal anti-inflammatory drugs (NSAIDs) rank among the most widely used medications worldwide, yet they are also a leading cause of adverse drug reactions. Hypersensitivity to NSAIDs encompasses a spectrum of clinical phenotypes that arise principally through cyclooxygenase‐1 (COX-1) inhibition, leading to an imbalance in the arachidonic acid cascade and overproduction of leukotrienes. These reactions are broadly classified into cross‐reactive forms, in which patients develop symptoms on exposure to chemically diverse NSAIDs, and selective responses, driven by immunological mechanisms to a single agent. Cross‐reactive phenotypes include NSAID-exacerbated respiratory disease (NERD), characterised by bronchoconstriction and nasal polyposis; NSAID-induced urticaria/angioedema (NIUA); and NSAID-exacerbated cutaneous disease (NECD). Selective reactions comprise immediate hypersensitivity (SNIUAA) and delayed responses (SNIDR), in which skin manifestations or systemic symptoms occur days after ingestion. Diagnosis relies on a detailed clinical history, in vitro assays in specialised laboratories, skin testing for delayed forms and, when necessary, controlled provocation challenges. Genetic predisposition plays an increasing role in understanding individual risk, while desensitisation protocols and avoidance strategies inform tailored management. Advances in phenotyping and molecular characterisation are reshaping precision approaches to analgesia in vulnerable populations.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs publication trend

The graph below shows the total number of articles in hypersensitivity reactions to nonsteroidal anti-inflammatory drugs across all publications each year (not limited to Nature Index journals).

Technical terms

Cyclooxygenase (COX): An enzyme critical to prostaglandin synthesis; its inhibition by NSAIDs diverts arachidonic acid to leukotriene production.

Arachidonic acid pathway: A lipid‐mediated inflammatory cascade that produces prostaglandins and leukotrienes, central to NSAID hypersensitivity mechanisms.

Cross‐reactive hypersensitivity: A pharmacological reaction pattern in which inhibition of COX-1 by one NSAID precipitates symptoms upon exposure to others.

Selectiv e hypersensitivity: Immune‐mediated reactions directed against a single NSAID, often presenting with immediate urticaria or delayed skin eruptions.

Provocation testing: A controlled oral or nasal challenge to confirm hypersensitivity when in vitro or skin tests are inconclusive.

References

  1. Genetic Susceptibility of HLA Alleles to Non-Steroidal Anti-Inflammatory Drug Hypersensitivity in the Taiwanese Population. Biomedicines (2023).
  2. NSAID hypersensitivity – recommendations for diagnostic work up and patient management. Allergo Journal International (2018).
  3. Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs. Frontiers in Genetics (2021).
  4. Genetic Variants in Cytosolic Phospholipase A2 Associated With Nonsteroidal Anti-Inflammatory Drug–Induced Acute Urticaria/Angioedema. Frontiers in Pharmacology (2021).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.